Zenchent Fe Kit
Product Images NDC 69238-1581

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Zenchent Fe (NDC 69238-1581). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Zenchent Fe 1)

A forest plot chart showing the risk of breast cancer associated with combined oral contraceptive use. The horizontal axis represents effect estimates (odds ratios/relative risks). The plot includes multiple studies from 2002 to 2017, comparing ever use and current use, with point estimates and confidence intervals plotted around the value of 1.0.*

FDA Label Image

4 (Zenchent Fe 10)

The image shows a label for Zenchent Fe, a kit of oral tablets containing Norethindrone and Ethinyl Estradiol (0.4 mg/35 mcg) and Ferrous Fumarate Tablets (75 mg). The label includes a weekly calendar guide for dosing and states the product is intended to prevent pregnancy but does not protect against HIV or other sexually transmitted diseases. The label also includes a barcode and the labeler is Amneal Pharmaceuticals NY LLC.*

FDA Label Image

Norethindrone (Zenchent Fe 2)

Chemical structure of Norethindrone and Ethinyl Estradiol, the active ingredients in Zenchent FE oral medication kit by Amneal Pharmaceuticals NY LLC.*

FDA Label Image

Ethinyl Estradiol (Zenchent Fe 3)

Chemical structure of Ethinyl Estradiol, one of the active ingredients in Zenchent FE (Norethindrone and Ethinyl Estradiol). The diagram shows the molecular structure featuring hydroxyl groups and an ethynyl group.*

FDA Label Image

Pi Figure (Zenchent Fe 4)

An instructional chart depicting the effectiveness of various birth control methods, arranged vertically from fewer to more pregnancies per 100 women per year. It categorizes methods such as implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring, condoms, diaphragm, spermicide, withdrawal, and abstinence during fertile days, indicating their relative pregnancy rates.*

FDA Label Image

Amneal Face Card (Zenchent Fe 5)

Zenchent Fe oral kit label by Amneal Pharmaceuticals NY LLC shows a 28-day dosing calendar with rows labeled for weeks 1 to 4 and days Sunday through Saturday. It includes chewable tablets containing Norethindrone and Ethinyl Estradiol 0.4 mg/35 mcg and Ferrous Fumarate 75 mg. The fourth week tablets are inactive. The label advises monthly self breast exams.*

FDA Label Image

Figure B (Zenchent Fe 6)

An instructional illustration showing hands opening a blister pack of oral tablets. Two arrows point to a single tablet being pushed out of the blister, demonstrating how to remove a pill from the packaging.*

FDA Label Image

Carton (Zenchent Fe 7)

Zenchent Fe kit packaging label for oral tablets containing Norethindrone and Ethinyl Estradiol, 0.4 mg/35 mcg, combined with Ferrous Fumarate Tablets, 75 mg. The label indicates 3 dispensers of 28 chewable tablets each, with specific details on tablet composition and lot number area. The product is by Amneal Pharmaceuticals NY LLC and marked Rx only.*

FDA Label Image

2 (Zenchent Fe 8)

Packaging label for Zenchent Fe 0.4 mg/35 mcg oral kit containing norethindrone and ethinyl estradiol chewable tablets and ferrous fumarate tablets. The kit includes one blister pack with 28 tablets, distributed by Amneal Pharmaceuticals LLC. The label notes it is prescription-only and includes dosage and storage information.*

FDA Label Image

3 (Zenchent Fe 9)

Zenchent Fe kit label from Amneal Pharmaceuticals NY LLC displays a four-week oral tablet schedule with days of the week arranged in rows, arrows guiding tablet intake order, and a note that tablets in week 4 are inactive. The product includes Norethindrone and Ethinyl Estradiol chewable tablets (0.4 mg/35 mcg) and Ferrous Fumarate tablets (75 mg). It features the NDC 69238-1581 barcode and a monthly self breast exam reminder.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.